Covidien Ltd. (NYSE: COV, BSX: COV) will report first-quarter
results before trading begins on February 7, 2008. The Company will
hold a conference call for investors at 8:30 a.m. ET. The call can be
accessed in the following ways:
-- At Covidien´s website: http://investor.covidien.com
-- By telephone: For both "listen-only" participants and those
participants who wish to take part in the question-and-answer
portion of the call, the telephone dial-in number in the U.S.
is 866-713-8310. For participants outside the U.S., the
dial-in number is 617-597-5308. The access code for all
callers is 96941212.
-- Through an audio replay: A replay of the conference call will
be available beginning at 10:30 a.m. on February 7, 2008, and
ending at 11:59 p.m. on February 14, 2008. The dial-in number
for U.S. participants is 888-286-8010. For participants
outside the U.S., the replay dial-in number is 617-801-6888.
The replay access code for all callers is 98144838.
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that
creates innovative medical solutions for better patient outcomes and
delivers value through clinical leadership and excellence. Covidien
manufactures, distributes and services a diverse range of
industry-leading product lines in five segments: Medical Devices,
Pharmaceutical Products, Imaging Solutions, Medical Supplies and
Retail Products. With 2007 revenue of $10 billion, Covidien has more
than 43,000 employees worldwide in 57 countries, and its products are
sold in over 130 countries. Please visit www.covidien.com to learn
more about our business.
